The Effect of an Alginate Based Beverage on Weight Loss

Exclusion Criteria

• •Chronic diseases including:liver and kidney disease, including P-Alanine aminotransferase (ALT), P-aspartate aminotransferase (AST), gamma-glutamyltransferase (GGT), creatinine kinase and P-lactate dehydrogenase (LD)\> 2.0 times the upper limit of normal (ULN) (measured at the screening at the Department of Human Nutrition)
• •systemic infections and metabolic diseases that can interfere with energy balance,
• •diabetes or fasting blood glucose concentration\> 7.0 mM, cardiovascular disease, systolic blood pressure ≥ 160 and / or a diastolic blood pressure ≥ 100 mmHg, hyperlipidemia (total cholesterol\> 6.5 mM and triglycerides\> 5.0 mM) (measured by the screening at the Department of Human Nutrition)
• •Food allergies
• •Psychiatric disorders and any clinical condition that makes the person unfit to participate in the experiment
• •Use of dietary supplements (during the experimental period and 3 months before study start)
• •Provision of blood for example. of donation or other scientific studies (during the trial and 3 months before study start) and hemoglobin \<7.5 mmol / l (measured at the screening at the Department of Human Nutrition)
• •Smoking (throughout the trial and 6 months before study start)
• •Elite Athletes (\> 10 hours strenuous exercise per week, self-reported)
• •Women who are pregnant or breastfeeding, and post-menustruelle (self reported)